Series A - Cradle Genomics

Series A - Cradle Genomics

Investment Firm

Overview

Cradle Genomics is a creator of a novel prenatal testing methodology

Announced Date

Jul 16, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Section 32

Section 32

Section 32 is a early_stage_venture and late_stage_venture and seed and venture firm.

Illumina Ventures

Illumina Ventures

Illumina Ventures is a debt and early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

5

Investor Name
Participant InvestorListwin Ventures
Participant InvestorAxon Ventures
Participant InvestorIllumina Ventures
Participant InvestorSection 32
Participant InvestorAlexandria Real Estate Equities

Round Details and Background

Cradle Genomics raised $17100000 on 2019-07-16 in Series A

Cradle Genomics is a creator of a novel prenatal testing methodology

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 16, 2019
Series A - Cradle Genomics
5-17.1M
Feb 19, 2020
Corporate Round - Cradle Genomics
1-6.0M

Recent Activity

There is no recent news or activity for this profile.